Captor Capital Corp. operates in the healthcare sector, focusing on the retail sale of cannabis products in the U.S. A key strength is its strong liquidity, evidenced by a current ratio of 13.53, indicating robust short-term financial health. However, concerns arise from negative returns on equity and assets, suggesting operational inefficiencies. The market cap is relatively low at $767.13K, and the recent decline in share price (-4.35%) may reflect investor sentiment amidst these financial challenges. Overall, while liquidity is a strength, profitability remains a significant concern.
Loading financial metrics...
Company posted a loss of $-24.1M over the last year, representing Infinity% of revenue.
Fortress balance sheet: cash covers total debt 22×, providing significant financial flexibility.
Excellent liquidity with current ratio of 13.5x ensures operational stability.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Drug Manufacturers - Specialty & Generic companies of a similar size
Based on 2026-Q3 (December 31, 2025)